Literature DB >> 16517929

Ulocladium atrum keratitis.

P R Badenoch1, C L Halliday, D H Ellis, K J Billing, R A D Mills.   

Abstract

We report a case of Ulocladium atrum keratitis in a 43-year-old man. No predisposing event was known. He received natamycin and fluconazole drops and the infection resolved. The isolate was identified by morphological and rRNA gene sequence analyses. U. atrum is a dematiaceous hyphomycete not hitherto reported to infect humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517929      PMCID: PMC1393132          DOI: 10.1128/JCM.44.3.1190-1193.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

Review 1.  Cutaneous infection caused by Ulocladium chartarum in a heart transplant recipient: case report and review.

Authors:  María Teresa Durán; Jesús Del Pozo; María Teresa Yebra; María Generosa Crespo; María Jesús Paniagua; María Angeles Cabezón; Josep Guarro
Journal:  Acta Derm Venereol       Date:  2003       Impact factor: 4.437

2.  Molecular characterization of Embellisia and Nimbya species and their relationship to Alternaria, Ulocladium and Stemphylium.

Authors:  Barry M Pryor; Donna M Bigelow
Journal:  Mycologia       Date:  2003 Nov-Dec       Impact factor: 2.696

3.  Detection and serotyping of herpes simplex virus in MRC-5 cells by use of centrifugation and monoclonal antibodies 16 h postinoculation.

Authors:  C A Gleaves; D J Wilson; A D Wold; T F Smith
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

4.  Improved tools for biological sequence comparison.

Authors:  W R Pearson; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay.

Authors:  S J Read; J B Kurtz
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

6.  [Cutaneous alternariosis revealing Cushing's disease. A case with ultrastructural study].

Authors:  J L Verret; F Gaborieau; D Chabasse; V Rohmer; M Avenel; A Smulevici
Journal:  Ann Dermatol Venereol       Date:  1982       Impact factor: 0.777

7.  Typification of Alternaria, Stemphylium, and Ulocladium.

Authors:  E G Simmons
Journal:  Mycologia       Date:  1967 Jan-Feb       Impact factor: 2.696

8.  Keratomycosis: clinical and microbiologic experience with dematiaceous fungi.

Authors:  P Garg; U Gopinathan; K Choudhary; G N Rao
Journal:  Ophthalmology       Date:  2000-03       Impact factor: 12.079

9.  Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India.

Authors:  M Srinivasan; C A Gonzales; C George; V Cevallos; J M Mascarenhas; B Asokan; J Wilkins; G Smolin; J P Whitcher
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

Review 10.  The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India.

Authors:  Usha Gopinathan; Prashant Garg; Merle Fernandes; Savitri Sharma; Sreedharan Athmanathan; Gullapalli N Rao
Journal:  Cornea       Date:  2002-08       Impact factor: 2.651

View more
  4 in total

Review 1.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

2.  An unusual phaeoid fungi: Ulocladium, as a cause of chronic allergic fungal sinusitis.

Authors:  R Kaur; A Wadhwa; A Gulati; Ak Agrawal
Journal:  Iran J Microbiol       Date:  2010-06

3.  Microbiological profile of corneal ulcer cases diagnosed in a tertiary care ophthalmological institute in Nepal.

Authors:  Sharmila Suwal; Dinesh Bhandari; Pratigya Thapa; Mohan Krishna Shrestha; Jyoti Amatya
Journal:  BMC Ophthalmol       Date:  2016-11-29       Impact factor: 2.209

4.  Causative fungi and treatment outcome of dematiaceous fungal keratitis in North India.

Authors:  Ajit Kumar; Ashi Khurana; Mohit Sharma; Lokesh Chauhan
Journal:  Indian J Ophthalmol       Date:  2019-07       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.